Delivery Order SPE2DB22D2206-SPE2DB24FGP43
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of 150mg Topiramate extended-release capsules. The $15,968.05 contract has an ultimate completion date of April 15, 2024. Amerisourcebergen Drug Corp is the prime contractor and does not have any major subcontractors identified. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of 4,564,147,373 Topiramate ER 50 mg capsules. The contract has a ceiling value of $7,768.59 and a period of performance through April 3, 2024. This delivery order is issued under an indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract, valued at $22,406.92, is for the delivery of 4,564,109,231 units of topiramate ER 100 mg capsules. The contract has an ultimate completion date of March 29, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,136,599 units of TOPIRAMATE ER 100 MG CAPSULE 100S. The $5,825.60 delivery order has a completion date of December 20, 2023. Amerisourcebergen Drug Corp is a prime contractor that has received multiple contracts from DLA to supply pharmaceuticals, medical supplies, and related distribution services to support military...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,107,029 units of 25mg topiramate tablets. The $17,464.86 contract has a completion date of March 29, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp also holds an indefinite delivery contract with DLA Troop Support Medical, valued at up to...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $5,484.94 contract is for the delivery of 4564043784 - Topiramate ER 50 mg Capsules in 30-count packages. The contract has a period of performance through March 22, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp also holds an indefinite...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order worth $35,031.13 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Topiramate ER 100 mg capsules. This order was placed under an indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp with DLA, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary vehicle for AmerisourceBergen to deliver...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $47,124.66 by the Defense Logistics Agency (DLA) on August 1, 2025, for the supply of Topiramate ER 100 mg capsules (30-count units). This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and a completion date of August 4, 2025. The contract will be performed at the contractor's corporate office location in Conshohocken, PA. This delivery order...
- The Defense Logistics Agency awarded a $6,774.81 delivery order to AmerisourceBergen Drug Corp for Topiramate ER 100 mg capsules (30-count units) on July 25, 2025, with completion scheduled for July 28, 2025. This non-competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and active through December 2026. The pharmaceutical distributor,...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, to provide TOPIRAMATE ER 200 MG CAPSULE 30S. The contract has a potential value of $6,111.95 and a completion date of February 8, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This delivery order contract is issued under a larger indefinite delivery contract (IDC) awarded...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB24FGP43Delivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 200 mg Topiramate ER capsules. The $48,858.73 contract has an ultimate completion date of April 10, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp, as the prime contractor, will deliver the pharmaceutical products from its Corporate Office location in Conshohocken, Pennsylvania to support military treatment programs and facilities. This delivery order is issued under an existing indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and performance period through December 31, 2025, which serves as the primary contract vehicle for Amerisourcebergen to provide a comprehensive range of medications and healthcare materials to the DLA Troop Support Medical.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $48.9k | 4/9/24 |